Clinical Trials Browser

Phase 2 × ofatumumab × Dermatologic × Clear all

NCT01376713 2015-10-06

Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic Melanoma

Phase 2 Completed

Melanoma